What do systematic reviews say?

Pregabalin vs placebo

Pregabalin may leads to higher adverse effect: dizziness compared with placebo (low certainty).

• Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  RR 3.15 [2.23, 4.44]
  7 studies · 2193 participants
  Low

Pregabalin vs placebo

Pregabalin showed no clear difference in adverse effect: fatigue compared with placebo (low certainty).

• Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  RR 1.35 [0.94, 1.93]
  8 studies · 2448 participants
  Low

Homeopathic medicinal products (individualised treatment) vs placebo or usual care

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 369 participants
  Low

Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care

It is very uncertain whether homeopathic medicinal products (non‐individualised treatment) changes adverse events compared with placebo or usual care (very low certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 0.26 [0.03, 2.43]
  1 study · 95 participants
  Very low

Homeopathic medicinal products vs placebo or usual care

It is very uncertain whether homeopathic medicinal products changes short‐term cure1 compared with placebo or usual care (very low certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 1.31 [0.09, 19.54]
  2 studies · 155 participants
  Very low

Homeopathic medicinal products vs placebo or usual care

It is very uncertain whether homeopathic medicinal products changes long‐term cure1 compared with placebo or usual care (very low certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 1.01
  2 studies · 155 participants
  Very low

Homeopathic medicinal products vs placebo or usual care

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 709 participants
  Low

Homeopathic medicinal products vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Homeopathic medicinal products vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Homeopathic medicinal products vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Homeopathic medicinal products vs placebo or usual care

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 75 participants
  Low

Homeopathic medicinal products (individualised treatment) vs placebo or usual care

Homeopathic medicinal products (individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (moderate certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 1.31 [0.64, 2.7]
  1 study · 199 participants
  Moderate

Homeopathic medicinal products (individualised treatment) vs placebo or usual care

Homeopathic medicinal products (individualised treatment) showed no clear difference in days off work for parents compared with placebo or usual care (moderate certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 1.46 [0.83, 2.55]
  1 study · 199 participants
  Moderate

Homeopathic medicinal products (individualised treatment) vs placebo or usual care

Homeopathic medicinal products (individualised treatment) showed no clear difference in need for antibiotics compared with placebo or usual care (low certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 0.79 [0.35, 1.76]
  2 studies · 369 participants
  Low

Homeopathic medicinal products (individualised treatment) vs placebo or usual care

Homeopathic medicinal products (individualised treatment) showed no clear difference in adverse events compared with placebo or usual care (moderate certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 2.51 [0.75, 8.42]
  1 study · 199 participants
  Moderate

Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care

Homeopathic medicinal products (non‐individualised treatment) showed no clear difference in recurrence of ARTI compared with placebo or usual care (low certainty).

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  OR 0.6 [0.21, 1.72]
  3 studies · 735 participants
  Low

Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Homeopathic medicinal products (non‐individualised treatment) vs placebo or usual care

The review found no eligible studies for this question.

• Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Any glucocorticoid vs no glucocorticoids or placebo

It is very uncertain whether glucocorticoids changes live birth rate per couple compared with no glucocorticoids or placebo (very low certainty).

• Peri‐implantation glucocorticoid administration for assisted reproductive technology cycles 2022 · Cochrane Headline outcomes only
  OR 1.37 [0.69, 2.71]
  2 studies · 366 participants
  Very low